AstraZeneca's Brilinta Fails Arterial Disease Drug Trial

AstraZeneca said its prescription blood-thinning medicine Brilinta failed to show a benefit over standard treatment in peripheral artery disease in a large clinical trial.

from WSJ.com: US Business http://ift.tt/2dG7fxD
via IFTTT